Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown

A tri-block nanoparticle (TBN) comprising of an enzymatically cleavable porous gelatin nanocore encapsulated with gefitinib (tyrosine kinase inhibitor (TKI)) and surface functionalized with cetuximab-siRNA conjugate has been synthesized. Targeted delivery of siRNA to undruggable KRAS mutated non-sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Srikar, R., Suresh, Dhananjay, Zambre, Ajit, Taylor, Kristen, Chapman, Sarah, Leevy, Matthew, Upendran, Anandhi, Kannan, Raghuraman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987653/
https://www.ncbi.nlm.nih.gov/pubmed/27530552
http://dx.doi.org/10.1038/srep30245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987653/
https://www.ncbi.nlm.nih.gov/pubmed/27530552
http://dx.doi.org/10.1038/srep30245

Ejemplares similares